CRVS · Corvus Pharmaceuticals, Inc. · Proposed Sales
Market Cap
$1.09B
Shares
84.12M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
61 filings
61 filers
Visit website
Investor relations